grant

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of mRNA, Lipid Nanoparticle Based HIV Immunogens

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 30 Aug 2023Deadline 28 Mar 2027
NIHUS FederalResearch GrantFY2023AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAntigensAreaAssayBioassayBiologic AssaysBiological AssayClinical EvaluationClinical TestingClinical TrialsContracting OpportunitiesContractsCyclic GMPDevelopmentDocumentationEncapsulatedGene TranscriptionGenerationsGenetic TranscriptionGood Manufacturing ProcessGood manufacturing practiceGuanosine Cyclic MonophosphateHIVHuman Immunodeficiency VirusesIn VitroInvestigational DrugsInvestigational New DrugsLAV-HTLV-IIILabelLipidsLymphadenopathy-Associated VirusManufactured MaterialsMessenger RNANIAIDNational Institute of Allergy and Infectious DiseasePhasePreclinical TestingProcessProductionRNA ExpressionReactionServicesTestingTranscriptionVaccinesVirus-HIVcGMPclinical testdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentalflexibilityflexibleimmunogenlipid based nanoparticlelipid nanoparticlemRNAmanufacturepre-clinicalpre-clinical testingpreclinicalproduct developmentprogramsresearch clinical testingstability testingvaccine development
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS): This program will provide NIAID with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents. Contracts under this program will provide the support and services needed for all stages of process and product development, small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submissions for Phase I, II, and III clinical testing. These capabilities will allow NIAID to rapidly and efficiently address development and production gaps. This contract will provide support under Task Area E, Process Development, cGMP Manufacturing and Stability.

Grant Number: 75N93022D00003-0-759302300001-1
NIH Institute/Center: NIH

Principal Investigator: WENDELL BERES

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of mRNA, Lipid Nanopartic | Dev Procure